Dial E J, Clarke D E
Res Commun Chem Pathol Pharmacol. 1977 May;17(1):145-56.
Monoamine oxidase (MAO) activity was characterized using whole tissue homogenates and kynuramine as the substrate. In rat vasa deferentia, kynuramine deamination was differentially inhibited by clorgyline, less so by deprenyl and not at all by pargyline. These studies, and mixed substrate experiments with tryptamine, proved that kynuramine is a substrate for MAO types A and B. Experiments made with rat abdominal aorta and inferior vena cava disclosed clorgyline-sensitive and resistant MAO activity, the latter being inhibited by semicarbazide but not by deprenyl or pargyline. No semicarbazide-sensitive species of MAO was found in human saphenous vein which also differed from the rat vasculature in that the predominant MAO activity was of the B type. It is concluded that kynuramine is also a good substrate for clorgyline-resistant enzymes and that rat vasculature may be a poor model for predicting deaminating mechanisms in human venous tissue.
使用全组织匀浆并以犬尿胺为底物对单胺氧化酶(MAO)活性进行了表征。在大鼠输精管中,氯吉兰对犬尿胺脱氨有不同程度的抑制作用,司来吉兰的抑制作用较小,而帕吉林则完全没有抑制作用。这些研究以及用色胺进行的混合底物实验证明,犬尿胺是A型和B型MAO的底物。对大鼠腹主动脉和下腔静脉进行的实验揭示了对氯吉兰敏感和耐药的MAO活性,后者可被氨基脲抑制,但不能被司来吉兰或帕吉林抑制。在人隐静脉中未发现对氨基脲敏感的MAO种类,人隐静脉与大鼠血管系统的不同之处还在于,其主要的MAO活性为B型。结论是,犬尿胺也是耐氯吉兰酶的良好底物,并且大鼠血管系统可能不是预测人静脉组织脱氨机制的理想模型。